Increasingly, economic data are being considered in formulary decisions. In oncology, pharmacoeconomic evaluations are essential to help decision makers weigh the associated costs and outcomes of competing
Tom Einarson, PhD
Advertisement
Articles by Tom Einarson, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer
2
Selecting Among Preferred 1L Regimens — A Discussion
3
What is the Future of TIL Therapy in Metastatic Melanoma?
4
Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors
5